2003
DOI: 10.1074/jbc.m302249200
|View full text |Cite
|
Sign up to set email alerts
|

Binding of Urokinase-type Plasminogen Activator Receptor (uPAR) to the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor

Abstract: Urokinase-type plasminogen activator receptor (uPAR) binding by the mannose 6-phosphate/insulinlike growth factor II receptor (Man-6-P/IGF2R) is considered important to Man-6-P/IGF2R tumor suppressor function via regulation of cell surface proteolytic activity. Our goal was to map the uPAR binding site of the Man-6-P/IGF2R by analyzing the uPAR binding characteristics of a panel of minireceptors containing different regions of the Man-6-P/IGF2R extracytoplasmic domain. Coimmunoprecipitation assays revealed tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(18 citation statements)
references
References 49 publications
0
18
0
Order By: Relevance
“…1C). The urokinase receptor (uPAR), a glycophosphatidylinositol-anchored protein that is associated with membrane lipid rafts and abundantly expressed in PC-3 cells (19), was present exclusively in the floating, nonnuclear fractions ( Fig. 1C), indicating the absence of significant cell membrane contamination of the nuclear fractions.…”
Section: Resultsmentioning
confidence: 99%
“…1C). The urokinase receptor (uPAR), a glycophosphatidylinositol-anchored protein that is associated with membrane lipid rafts and abundantly expressed in PC-3 cells (19), was present exclusively in the floating, nonnuclear fractions ( Fig. 1C), indicating the absence of significant cell membrane contamination of the nuclear fractions.…”
Section: Resultsmentioning
confidence: 99%
“…The luminal CDMPR monomer contains a single Man-6-P binding site while two of the repeating units on the CIMPR contain the high affinity binding sites (domains 3 and 9) and domain 11 contains the IGF2 binding site. The CIMPR may also bind urokinase-type plasminogen activator receptor at a site distinct from the Man-6-P and IGF2 binding sites (54), but this is controversial (55). Given the multiple domains of the CIMPR, it is possible that there are additional, as yet unidentified, ligands for this receptor.…”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that IGF2R may serve other functions in addition to acting as a negative regulator of IGF2 ligand bioavailability [57]. For example, in other cell types IGF2R can bind urokinase-type plasminogen activator receptor and plasminogen [58,59], and it may be a receptor for retinoic acid [60]. Whether these other functions of the IGF2R are operative in ovarian tissue or granulosa cells in particular will require further elucidation.…”
Section: Spicer and Aadmentioning
confidence: 99%